First CRISPR medicine now in the US
On December 8, The US Food and Drug Administration approved a first-of-its-kind treatment that involves CRISPR gene editing. Casgevy therapy treats patients with sickle cell disease, which is an inherited blood disorder. Vence Bonham, acting deputy director of the National Human Genome Research Institute, said, “This is a major milestone.” Many have been skeptical about
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.